Furthermore, a mouse p53 mutant deleted for the proline-rich domain (p53Δp) showed enhanced p53Δp-mediated suppression of oncogene-induced tumors after MDM4 loss, supporting MDM4 as an anti-cancer target (54). This evidence concerns the gene MDM4 and cancer.